ArticleJournal of assisted reproduction and genetics2026
The effect of severe oligozoospermia on embryo dynamics and morphological quality.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study evaluated whether severe oligozoospermia affects early cleavage-stage dynamics and blastocyst developmental competence in ICSI cycles cultured in a time-lapse system.
methodsThis retrospective matched cohort study included ICSI cycles using fresh ejaculated sperm and fresh autologous oocytes at Assisted Reproductive Center, Tam Anh Hanoi General Hospital (February 2022-December 2024). Initially, eligible cycles were identified in both groups. After propensity score matching (1:2), the final analytic cohort comprised 39 cycles in the severe oligozoospermia group and 78 cycles in the normozoospermia group. All normally fertilized zygotes (2PN) were monitored up to day 7. Cleavage-stage morphokinetic parameters and abnormal cleavage patterns were analyzed. Multivariate analyses evaluated overall morphokinetic differences. A generalized linear mixed model (GLMM) tested predictors of usable blastocysts, comparing 4095 candidate models based on the Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC).
resultsA total of 117 ICSI cycles were analyzed after propensity score matching, including 39 cycles with severe oligozoospermia and 78 normozoospermic controls. Despite a significantly higher number of retrieved MII oocytes, the severe oligozoospermia group exhibited lower fertilization rates (71.33% vs. 77.98%, p = 0.012) and a reduced proportion of top-quality day-3 embryos (51.25% vs. 65.82%, p < 0.001). Blastocyst formation and top-quality blastocyst rates did not differ significantly between groups. Cleavage-stage morphokinetic analysis revealed a statistically significant prolongation of the second cell cycle (ECC2) in the severe oligozoospermia group; however, the absolute difference was small (~ 0.25 h) and accounted for a limited proportion of variance (R
conclusionsSevere oligozoospermia was associated with impaired fertilization outcomes and reduced day-3 embryo quality. A modest but statistically significant prolongation of ECC2 was observed; however, when sperm concentration was evaluated in isolation under ICSI conditions, later cleavage-stage morphokinetics and blastocyst development appeared largely preserved at the laboratory level. These findings are limited to sperm concentration alone and may be influenced by unmeasured sperm functional defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.